EPA’s Scott Pruitt Doesn’t Buy Evolution

In audio files from 2005, the future Administrator of the EPA said there’s a lack of “sufficient scientific facts” to back the theory.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, UNITED STATES ENVIRONMENTAL PROTECTION AGENCYThe administrator of the US Environmental Protection Agency (EPA), Scott Pruitt, said that evolution, at least as it concerns the origins of humans, is a philosophical and not scientific matter, according to audio from a 2005 radio show unearthed by Politico. “There aren’t sufficient scientific facts to establish the theory of evolution,” Pruitt said.

It’s not clear how Pruitt’s disregard for a basic tenet of modern biology affects his work at the agency. But Republican lawmakers tell Politico that Pruitt’s faith—he is an evangelical Christian—should indeed guide his decisions. “He’s a believer. He is a Jesus guy. He believes in the principles,” Senator Jim Inhofe (R-OK) tells Politico. “I think it does [have an impact], and I think it has to. Anyone who denies that that has an impact isn’t being totally honest.”

Andrew Rosenberg, director of the Center for Science and Democracy at the Union of Concerned Scientists, counters that Pruitt should not act as “the nation’s pastor.”

Pruitt has questioned the contributions of humans to climate change, and his policy decisions have attempted to roll back environmental ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies